Malaysia buys additional 12.2 million doses of Pfizer-BioNTech Covid-19 vaccine
[KUALA LUMPUR] Malaysia on Monday signed a deal to buy an additional 12.2 million doses of a Covid-19 vaccine manufactured by US and German drugmakers Pfizer and BioNTech, the health ministry said in a statement.
The deal brings the total amount of the Pfizer vaccines procured by Malaysia to 25 million doses, enough to cover 39 per cent of its population, the ministry said.
REUTERS
A NEWSLETTER FOR YOU
Asean Business
Business insights centering on South-east Asia's fast-growing economies.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
International
Human cases of bird flu 'an enormous concern', says WHO
Copenhagen mayor to take lessons from Notre-Dame after Old Stock Exchange blaze
Reuters’ Mohammed Salem wins 2024 World Press Photo of the Year award
Europe’s Red Letta day to consider major reforms
Norway's wealth fund posts US$109 billion Q1 profit as tech stocks soar
Norway wealth fund backs NatWest plan to buy more state-owned stock